Assessment of regulatory needs list

Assessment of regulatory needs list

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™)

covering any of its individual anti- and syn-isomers or any combination thereof EC / List no: - CAS no: -
Concern
Bioaccumulation
Persistence
Status
Concluded
Outcome
Appropriate to initiate regulatory risk management action
Follow-up
SVHC
Date of intention
04/03/2016
Date of RMOA conclusion
10/08/2018
RMOA conclusion document
Full RMOA document
Remarks
Authority
United Kingdom
Submitter organisation
Health and Safety Executive
Submitter email
UKREACHCA@hse.gsi.gov.uk
Submitter phone
Submitter address
Co-submitter(s)
Latest update
10/08/2018

Help Help
Group members
This group of substance has the following member substances:
Results list is empty

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.